Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Xcel Brands Announces Participation in Noble Capital Markets C-Suite Interview Series
-
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
-
Banzai Gives Business Update Including End-of-Year 2023 ARR, Additional Executed LOI and End-of-Year 2024 ARR Target
-
Review Control (OTC: IMTL) Set to Announce Its Newest Business Service, Two Cent Texts, Revolutionizing the Growing 12.6 Billion Dollar per Year Business-to-Consumer SMS Text Messaging Service
-
DADA NEXUS LIMITED (NASDAQ: DADA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Dada Nexus Limit
-
Finacity Reaches Record Milestone: $1 Trillion of Trade Receivables Financed Over the Past 5 Years
-
SPIRIT AEROSYSTEMS HOLDINGS, INC. (NYSE: SPR) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Spirit AeroSystems Holdings, Inc.
-
ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Ho
-
GENERAL MOTORS COMPANY (NYSE: GM) INVESTIGATION ALERT: Bernstein Liebhard is Investigating General Motors Company
-
Kratos Orders Nine Zeus 1 and Zeus 2 Rocket Motors in Preparation for Initial Customer Funded Flights
-
APAC Based Digital and Social Media Network ‘VS Media’ Announce Strategic Investment and Partnership with LA Creative Venture Studio ‘MeeshQ’
-
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
-
Absci to Participate in Upcoming Investor Conferences
-
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
-
Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
-
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
-
Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer
-
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
-
Restaurant-Tech Leader Crunchtime Expands Global Operations and Surpasses $100 Million in Revenue
-
Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024
-
Lisata Therapeutics to Present at BIO CEO & Investor Conference
-
Form 8.3 - [ LXi REIT PLC - 19 02 2024] - (CGWL)
-
CNH takes minority investment in drone imaging AI company Bem Agro
-
Ledelsesændring i Nordea Funds Oy
-
60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris
-
Recursion to Host Public L(earnings) Call on February 27
-
Zerify Updates Shareholders on Key Developments
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 19 02 2024] - (CGWL)
-
IntelGenx Launches Preferred Share Regulation A Offering
-
Methanex Provides Update on Geismar 3 Methanol Plant in Geismar, Louisiana
-
Methanex Provides Update on Geismar 3 Methanol Plant in Geismar, Louisiana
-
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
-
Beyond, Inc. Announces Key Leadership Changes
-
Applied Materials to Participate in the Morgan Stanley Technology, Media & Telecom Conference
-
Applied Materials to Participate in the Morgan Stanley Technology, Media & Telecom Conference
-
Enstar Group Limited Reports Fourth Quarter and 2023 Year-End Results
-
VitalHub UK Expands Healthtech Portfolio into Middle East through a Partnership with ADHDS
-
California’s Foothill Transit to add 12 Enviro500EV double deck zero-emission buses from NFI subsidiary Alexander Dennis
-
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
-
Simon Lussier Joins Midland’s Board of Directors
-
Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
-
Marcus Lemonis Appointed Executive Chairman of Beyond, Inc.
-
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
-
Agrify Corporation Announces Turnkey Ethanol Extraction Deployment in New Jersey with Denver Cole
-
Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action
-
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook
-
Malibu Boats, Inc. Announces Leadership Changes
-
nCino to Participate in Upcoming Investor Event

